Cargando…
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
New genetic variants of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) constantly emerge through unmitigated spread of the virus in the ongoing Coronavirus disease 2019 pandemic. Omicron (B.1.1.529), the latest variant of concern (VOC), has so far shown exceptional spread and infectivi...
Autores principales: | Ao, Danyi, Lan, Tianxia, He, Xuemei, Liu, Jian, Chen, Li, Baptista‐Hon, Daniel T., Zhang, Kang, Wei, Xiawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925644/ https://www.ncbi.nlm.nih.gov/pubmed/35317190 http://dx.doi.org/10.1002/mco2.126 |
Ejemplares similares
-
The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
por: Ao, Danyi, et al.
Publicado: (2023) -
Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants
por: Lei, Hong, et al.
Publicado: (2022) -
Escape of SARS-CoV-2 Variant Omicron to Mucosal Immunity in Vaccinated Subjects
por: Martinuzzi, Emanuela, et al.
Publicado: (2022) -
SARS-CoV-2 variants, immune escape, COVID-19 vaccine, and therapeutic strategies
por: Que, Haiying, et al.
Publicado: (2022) -
SARS‐CoV‐2 Omicron variant: Characteristics and prevention
por: He, Xuemei, et al.
Publicado: (2021)